Epitel, Inc. vs SignaCor Therapeutics
Epitel, Inc. vs SignaCor Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epitel, Inc. is on 58/100 and SignaCor Therapeutics on 46/100.
Where each one leads
Epitel, Inc.
- our overall score: 58/100 against 46/100
- funding raised: $26.0M against $315K
SignaCor Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Epitel, Inc. | SignaCor Therapeutics |
|---|---|---|
| What it is | Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy. | Clinical-stage drug development company advancing treatments for hypertrophic cardiomyopathy and cardiovascular health. |
| Category | HealthTech, Medical Devices, Artificial Intelligence, Biotechnology | HealthTech, Biotechnology, Cardiovascular Health, Cardiovascular |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Services |
| Founded | 2017 | 2024 |
| Headquarters | Salt Lake City, United States | Belfast, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Epitel, Inc. | SignaCor Therapeutics |
|---|---|---|
| Total funding | $26.0M | $315K |
| Latest round | Series B | Seed |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epitel, Inc. | SignaCor Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 58/100 | 46/100 |
| Traction | 37/100 | 27/100 |
| Team | 30/100 | 60/100 |
| Search visibility | 21/100 | 13/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | Not published |
| Domain ratingLink authority, 0-100 | 40/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epitel, Inc. | SignaCor Therapeutics |
|---|---|---|
| CMS | Wix | Not detected |
Epitel, Inc. vs SignaCor Therapeutics: common questions
Which is better, Epitel, Inc. or SignaCor Therapeutics?
On our 0-100 score Epitel, Inc. rates higher (58/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Epitel, Inc. and SignaCor Therapeutics compare on the numbers?
Epitel, Inc. leads on our overall score (58/100 against 46/100), funding raised ($26.0M against $315K).
Read the full Epitel, Inc. review and pricing or the SignaCor Therapeutics review and pricing. You can also browse other Epitel, Inc. alternatives we track.